Who owns Lineage Cell Therapeutics In call?

Tip: Access positions for across all investors

Analyze quarterly positions in Lineage Cell Therapeutics In call with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lineage Cell Therapeutics In call stock

Who bought or sold Lineage Cell Therapeutics In call this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Group One Trading 146k $215k 504% Mar 2024
 View chart